Search
for
Sort by
Research 151–180 of 527
- Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms
- Steroid 5α-Reductase as a Novel Therapeutic Target for Schizophrenia and Other Neuropsychiatric Disorders
- Focus on Skin as a Possible Port of Entry for Solid Nanoparticles and the Toxicological Impact
- Cutaneous and Mucosal Manifestations Associated with Celiac Disease
- Dermatologic Manifestations of Human Immunodeficiency Virus Infection
- Microneedle-Based Approaches for Skin Disease Treatment
- Malignancy and Cancer Treatment-Related Hair and Nail Changes
- Effects of autologous platelet‑rich plasma injections on facial skin rejuvenation
- Factors associated with female pattern hair loss and its prevalence in Taiwanese women: A community-based survey
- Hair removal using an Nd: YAG laser system.
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Hair growth stimulatory effect by a combination of 5-aminolevulinic acid and iron ion
- Cutaneous manifestations of metabolic diseases: uncommon presentations
- ADVANCES IN PSORIASIS THERAPY
- The quality of European dermatological guidelines: critical appraisal of the quality of EDF guidelines using the AGREE II instrument
- Adverse cutaneous reactions to chemotherapeutic agents and cytokine therapy
- The Hair Growth-Promoting Effect of<i>Rumex japonicus</i>Houtt. Extract
- Non‐infective mucocutaneous presentations of human immunodeficiency virus infection
- Proprietary Herbal Extract Downregulates the Gene Expression of Il-1 and #945; in HaCaT Cells: Possible Implications Against Nonscarring Alopecia
- Combination of tacalcitol ointment and photodynamic therapy for the treatment of follicular mucinosis of the scalp
- Plant Extracts in Skin Care Products
- Hair Follicle Targeting with Nanoparticles
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- Diseases of the Hair and Nails
- 277 An open label pilot clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- A systematic review of randomized controlled trials assessing phytochemicals and natural ingredients for skin and hair care
- Inherited Disorders of the Hair
- Chapter 14 Principles of drug metabolism
- Cutaneous drug reactions
- Haut und Haar